SCHEMBL8056470

SCHEMBL8056470

CCc1cc2c(cc1C(=O)OC)S(=O)(=O)C(C)C=C2

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.34
HTT P42858 1/20 0.34
TSHR P16473 2/20 0.33
KDM4E B2RXH2 8/20 0.32
HSD17B10 Q99714 5/20 0.32
MAPT P10636 4/20 0.32
HPGD P15428 5/20 0.32
LMNA P02545 2/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
ATM Q13315 1/20 0.31
KMT2A Q03164 3/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8060802 0.84 ALDH1A1 (0.35) ALDH1A1TSHRKDM4EHSD17B10MAPT
SCHEMBL8062874 0.78 CA9 (0.39) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8056361 0.75 ALDH1A1 (0.33) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8057086 0.74 ALDH1A1 (0.32) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8057108 0.72 MEN1 (0.34) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8045201 0.72 TSHR (0.34) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8057109 0.71 ALDH1A1 (0.34) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8056207 0.71 TSHR (0.33) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8056246 0.70 DRD2 (0.37) ALDH1A1HTTTSHRKDM4EHSD17B10
SCHEMBL8056970 0.69 ALDH1A1 (0.33) ALDH1A1HTTTSHRKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6028069-A Heterocyclyl-condensed benzoylguanidines, their production and use as inhibitors of the cellular Na+/H+-antiporter MERCK PATENT GESELLSCHAFT MIT BERSCHRANKER HAFTUNG (DE) 2000-02-22 US disclosed